Finanzen von Longevity Health Holdings Inc (XAGE)XAGELongevity Health Holdings Inc

Evaluating the bottom line, Longevity Health Holdings Inc maintains a gross margin of 55.69%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -369.05%, while the net margin is -374.58%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively XAGE converts its operational activities into shareholder value.

In the context of the broader market, XAGE competes directly with industry leaders such as GIBO and FRGT. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, XAGE's gross margin of 55.69% stands against GIBO's 84.74% and FRGT's -88.51%. Such benchmarking helps identify whether Longevity Health Holdings Inc is trading at a premium or discount relative to its financial performance.